These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31142066)

  • 1. [The subgroup analysis of the prognostic value of the intraductal carcinoma of the prostate in patients with metastatic prostate cancer].
    Zhao JG; Nie L; Chen XQ; Chen N; Zeng H
    Zhonghua Wai Ke Za Zhi; 2019 Jun; 57(6):422-427. PubMed ID: 31142066
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?
    Zhao T; Liao B; Yao J; Liu J; Huang R; Shen P; Peng Z; Gui H; Chen X; Zhang P; Zhu Y; Li X; Wei Q; Zhou Q; Zeng H; Chen N
    Prostate; 2015 Feb; 75(3):225-32. PubMed ID: 25307858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and oncologic findings of extraprostatic extension on needle biopsy in
    Chen JR; Zhao JG; Zhu S; Zhang MN; Chen N; Liu JD; Sun GX; Shen PF; Zeng H
    Asian J Androl; 2020; 22(4):427-431. PubMed ID: 31424026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer.
    Zhao J; Liu J; Sun G; Zhang M; Chen J; Shen P; Liu Z; Liao B; Zhang X; Gong J; Chen N; Zeng H;
    J Urol; 2019 Apr; 201(4):759-768. PubMed ID: 30652989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic parameter for high risk prostate cancer patients at initial presentation.
    Kato M; Kimura K; Hirakawa A; Kobayashi Y; Ishida R; Kamihira O; Majima T; Funahashi Y; Sassa N; Matsukawa Y; Hattori R; Gotoh M; Tsuzuki T
    Prostate; 2018 Jan; 78(1):11-16. PubMed ID: 29094384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of perineural invasion in patients with de novo metastatic prostate cancer.
    Zhao J; Chen J; Zhang M; Tang X; Sun G; Zhu S; Liu J; Zhang H; Zhang X; Yin X; Zhao P; Zhu X; Ni Y; Dai J; Shen P; Chen N; Zeng H
    Andrology; 2019 Mar; 7(2):184-192. PubMed ID: 30609313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy.
    Van der Kwast T; Al Daoud N; Collette L; Sykes J; Thoms J; Milosevic M; Bristow RG; Van Tienhoven G; Warde P; Mirimanoff RO; Bolla M
    Eur J Cancer; 2012 Jun; 48(9):1318-25. PubMed ID: 22405699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
    Wu T; Zhao J; Liu Z; Shen P; Zhang M; Sun G; Liu J; Liao B; Chen J; Zhu S; Dai J; Wang Z; Zhang H; Zhao P; Zhang X; Zhu X; Ni Y; Chen N; Zeng H
    Prostate; 2019 Oct; 79(14):1673-1682. PubMed ID: 31433509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.
    Saeter T; Vlatkovic L; Waaler G; Servoll E; Nesland JM; Axcrona K; Axcrona U
    Prostate; 2017 Jun; 77(8):859-865. PubMed ID: 28240424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the presence of intraductal carcinoma of the prostate and bone metastasis in needle biopsy for prostate carcinoma patients with Grade Group 5.
    Chen X; Yang Y; Wang W; Han B; Qi M; Geng S; Xu J; Zhang Q; Wang X; Chen S; Shi K; Ke X; Zhang J
    Pathol Res Pract; 2020 Jan; 216(1):152693. PubMed ID: 31734052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
    Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
    Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.
    Trinh VQ; Sirois J; Benzerdjeb N; Mansoori BK; Grosset AA; Albadine R; Latour M; Mes-Masson AM; Hovington H; Bergeron A; Ladouceur M; Fradet Y; Saad F; Trudel D
    Prostate; 2018 Jul; 78(10):697-706. PubMed ID: 29603326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of intraductal carcinoma of the prostate is closely associated with poor prognosis: a systematic review and meta-analysis.
    Zhang YC; Sun GL; Ma DL; Wei C; Shang HJ; Liu Z; Li R; Wang T; Wang SG; Liu JH; Liu XM
    Asian J Androl; 2021; 23(1):103-108. PubMed ID: 32496222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
    Tom MC; Nguyen JK; Lucianò R; Mian OY; Stephans KL; Ciezki JP; Smile TD; Wei W; McKenney JK; Magi-Galluzzi C; Tendulkar RD
    J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
    Jeyapala R; Savio AJ; Olkhov-Mitsel E; Kamdar S; Zhao F; Cuizon C; Liu RSC; Zlotta A; Fleshner N; van der Kwast T; Bapat B
    Eur Urol Oncol; 2019 May; 2(3):231-238. PubMed ID: 31200836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer.
    Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Naito Y; Tochigi K; Sano T; Ishida S; Funahashi Y; Fujita T; Matsukawa Y; Hattori R; Tsuzuki T
    Int J Clin Oncol; 2020 Dec; 25(12):2130-2137. PubMed ID: 32748295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.
    Khani F; Epstein JI
    Am J Surg Pathol; 2015 Oct; 39(10):1383-9. PubMed ID: 26076065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer.
    Zhu S; Zhao JG; Chen JR; Liu ZH; Sun GX; Wang ZP; Ni YC; Dai JD; Shen PF; Zeng H
    Asian J Androl; 2020; 22(5):519-525. PubMed ID: 31710002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
    Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
    Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.